{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:02:23Z","timestamp":1740146543421,"version":"3.37.3"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H05291"],"award-info":[{"award-number":["15H05291"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0223390","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T13:24:01Z","timestamp":1570195441000},"page":"e0223390","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circulating levels of CD34+ cells predict long-term cardiovascular outcomes in patients on maintenance hemodialysis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-6798","authenticated-orcid":true,"given":"Ahmad Baseer","family":"Kaihan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Naseer","family":"Kaihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotake","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"pone.0223390.ref001","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study","volume":"65","author":"AK Cheung","year":"2004","journal-title":"Kidney Int"},{"key":"pone.0223390.ref002","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1681\/ASN.2005090958","article-title":"Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients","volume":"17","author":"K Yasuda","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"pone.0223390.ref003","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"AK Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"pone.0223390.ref004","first-page":"S2","volume-title":"Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation","author":"T Moeslinger","year":"2001"},{"key":"pone.0223390.ref005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"K Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"pone.0223390.ref006","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.RES.0000099245.08637.CE","article-title":"Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1-Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells","volume":"93","author":"S Fujiyama","year":"2003","journal-title":"Circ Res"},{"key":"pone.0223390.ref007","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/01.CIR.0000096490.16596.A6","article-title":"Isolation and Transplantation of Autologous Circulating Endothelial Cells into Denuded Vessels and Prosthetic Grafts: Implications for Cell-Based Vascular Therapy","volume":"108","author":"DP Griese","year":"2003","journal-title":"Circulation"},{"key":"pone.0223390.ref008","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1161\/01.CIR.0000018166.84319.55","article-title":"Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells","volume":"105","author":"DH Walter","year":"2002","journal-title":"Circulation"},{"key":"pone.0223390.ref009","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.CIR.0000096483.29777.50","article-title":"Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells","volume":"108","author":"C Urbich","year":"2003","journal-title":"Circulation"},{"key":"pone.0223390.ref010","first-page":"653","volume-title":"Nature Medicine","author":"P Carmeliet","year":"2003"},{"key":"pone.0223390.ref011","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7434","article-title":"Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization","volume":"5","author":"T Takahashi","year":"1999","journal-title":"Nat Med"},{"key":"pone.0223390.ref012","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"N Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"pone.0223390.ref013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/dc16-1755","article-title":"Long-term Prediction of Cardiovascular Outcomes by Circulating CD34 + and CD34 + CD133 + Stem Cells in Patients With Type 2 Diabetes","volume":"40","author":"GP Fadini","year":"2017","journal-title":"Diabetes Care"},{"key":"pone.0223390.ref014","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events","volume":"111","author":"C Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"key":"pone.0223390.ref015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.atherosclerosis.2009.03.040","article-title":"Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes","volume":"207","author":"GP Fadini","year":"2009","journal-title":"Atherosclerosis"},{"key":"pone.0223390.ref016","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jdi.12310","article-title":"Decreased levels of circulating CD34 + cells are associated with coronary heart disease in Japanese patients with type 2 diabetes","volume":"6","author":"H Makino","year":"2015","journal-title":"J Diabetes Investig"},{"key":"pone.0223390.ref017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000430471","article-title":"Circulating Endothelial Progenitor Cell Levels Predict Cardiovascular Events in End-Stage Renal Disease Patients on Maintenance Hemodialysis","volume":"130","author":"HJ o. Lee","year":"2015","journal-title":"Nephron"},{"key":"pone.0223390.ref018","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/ki.2008.495","article-title":"Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients","volume":"74","author":"S Maruyama","year":"2008","journal-title":"Kidney Int. Elsevier Masson SAS"},{"key":"pone.0223390.ref019","article-title":"Endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease","author":"CO Aragona","year":"2016","journal-title":"Stem Cells International"},{"key":"pone.0223390.ref020","article-title":"Smoking and Endothelial Progenitor Cells: A Revision of Literature","author":"R Di Stefano","year":"2010","journal-title":"Curr Pharm Des"},{"key":"pone.0223390.ref021","first-page":"2081","article-title":"Aging of Progenitor Cells: Limitation for Regenerative Capacity?","volume":"42","author":"S Dimmeler","year":"2003","journal-title":"J Am Coll Cardiol. Elsevier Masson SAS"},{"key":"pone.0223390.ref022","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1161\/01.CIR.0000133311.25587.DE","article-title":"Circulating CD34-positive cells provide an index of cerebrovascular function","volume":"109","author":"A Taguchi","year":"2004","journal-title":"Circulation"},{"key":"pone.0223390.ref023","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1538-7836.2009.03540.x","article-title":"Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients","volume":"7","author":"N JOURDE-CHICHE","year":"2009","journal-title":"J Thromb Haemost"},{"key":"pone.0223390.ref024","article-title":"Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects","author":"G Mandraffino","year":"2017","journal-title":"PLoS One"},{"key":"pone.0223390.ref025","article-title":"Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors","author":"C Urbich","year":"2005","journal-title":"Kidney International"},{"key":"pone.0223390.ref026","article-title":"Endothelial Progenitor Cells in Cardiovascular Disorders","author":"E Shantsila","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"pone.0223390.ref027","article-title":"Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk","author":"JM Hill","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"pone.0223390.ref028","article-title":"Vascular repair by endothelial progenitor cells","author":"A Zampetaki","year":"2008","journal-title":"Cardiovascular Research"},{"key":"pone.0223390.ref029","first-page":"425","article-title":"Increased haematopoietic activity in patients with atherosclerosis","volume":"38","author":"FM Van Der Valk","year":"2017","journal-title":"Eur Heart J"},{"key":"pone.0223390.ref030","article-title":"Cardiovascular disease in dialysis patients","author":"M Cozzolino","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0223390.ref031","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/eurheartj\/ehl198","article-title":"Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk","volume":"27","author":"GP Fadini","year":"2006","journal-title":"Eur Heart J"},{"key":"pone.0223390.ref032","article-title":"Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model","author":"A Taguchi","year":"2004","journal-title":"J Clin Invest"},{"key":"pone.0223390.ref033","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.CIR.0000136813.89036.21","volume":"110","author":"M Valgimigli","year":"2004","journal-title":"Circulation"},{"key":"pone.0223390.ref034","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"DW Losordo","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0223390.ref035","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3727\/096368916X691484","article-title":"Autologous CD34+ Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study","volume":"25","author":"TD Henry","year":"2016","journal-title":"Cell Transplant"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0223390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:52:47Z","timestamp":1588967567000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0223390"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0223390","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,10,4]]}}}